The Food and Drug Administration issued updated cybersecurity guidance for medical devices, setting stricter requirements that many existing systems  and the software that runs them  cannot meet without significant redesign. The FDAs updated guidance, enacted through the omnibus appropriations legislation known as Section 524B, marks a major shift in how device security is regulated. The new framework requires manufacturers to implement security throughout the product lifecycle, including documenting software components, managing vulnerabilities and maintaining secure development processes&